Prevalence of ROS1 fusion in Chinese patients with non‐small cell lung cancer

201849 citationsJournal Articlegold Open Access

Authors

Qing Zhang · Shanghai Chest Hospital

Chunyan Wu · Tongji University

Wei Ding · Second Affiliated Hospital of Zhejiang University

Zhihong Zhang · Jiangsu Province Hospital

Xueshan Qiu · First Hospital of China Medical University

Dianbin Mu · Shandong Tumor Hospital

Haiqing Zhang

Abstract

An overall ROS1 fusion frequency of 2.59% was confirmed in this study. ROS1 fusion was more prevalent among younger patients, never-smokers, and those at advanced node stages.

Topics & Keywords

Lung Cancer Treatments and Mutations RNA and protein synthesis mechanisms RNA modifications and cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Thoracic Cancer

Volume 10, Issue 1, pp. 47-53

DOI: 10.1111/1759-7714.12899

Field-Weighted Citation Impact: 2.76